Buprenorphine And Naloxone Film, Soluble
Product Images NDC 43598-579

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 43598-579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

FDA Label Image

Carton2 (Carton2)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Pouch1 (Pouch1)

FDA Label Image

Pouch2 (Pouch2)

This is a product information for DrReddys 4, NDC 43598-58, a prescription drug consisting of Buprenorphine and Naloxone in the form of sublingual film, with a strength of 8mg/2mg. The product is designed to treat patients with opioid addiction by reducing withdrawal symptoms. The package contains 113 neurons of sublingual film, and the drug is intended for sublingual administration only. The text also includes a prescription code (Rx only) and a set of unreadable numbers.*

FDA Label Image

Structure1 (Structure1)

CoHyNO is a chemical compound with a molecular weight of 504.10. HC1 may also be associated with this compound. No additional information is available from the provided text.*

FDA Label Image

Structure2 (Structure2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.